Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer?

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 6109-6114

  Aydiner, Adnan ^a   Ciftci, Rumeysa ^a   Karabulut, Senem ^a   Kilic, Leyla ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Beta blockers; Non small cell lung cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMORBIDITY; DRUG COMBINATION; DRUG POTENTIATION; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; COMORBIDITY; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84890510598     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.6109     Document Type: Article

References (34)

1. Al-Wadei HA, Schuller HM (2009). Nicotinic receptorassociated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas. J Pathol, 218, 437-45.
2. Al-Wadei HA, Plummer HK, Schuller HM (2009). Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. Carcinogenesis, 30, 506-11.
3. Al-Wadei HA, Al-Wadei MH, Ullah MF, et al (2012). Gammaamino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma. Curr Cancer Drug Targets, 12, 97-106.
4. Al-Wadei HA, Ullah MF, Al-Wadei MH (2012). Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: Implications for anti-cancer drug targets. Pharmacol Res, 66, 33-40.
5. Al-Wadei HA, Al-Wadei MH, Schuller HM (2012). Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: A novel target for intervention. PLoS One, 7, 29915.
6. Arredondo J, Chernyavsky AI, Grando SA (2006). Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol Ther, 5, 511-7.
7. Ben-Eliyahu S, Shakhar G, Page GG, et al (2000). Suppression of NK cell activity and of resistance to metastasis by stress: A role for adrenal catecholamines andbeta-adrenoceptors. Neuroimmunomodulation, 8, 154-64.
8. Carlisle DL, Liu X, Hopkins TM, et al (2007). Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. Pulm Pharmacol Ther, 20, 629-41.
9. Catassi A, Servent D, Paleari L, et al (2008). Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: Implications on lung carcinogenesis. Mutat Res, 659, 221-31.
10. Cole SW, Sood AK (2012). Molecular pathways: Beta-adrenergic signaling in cancer. Clin Cancer Res, 18, 1201-6.
11. Drell TL, Joseph J, Lang K, et al (2003). Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat, 80, 63-70.
12. Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66.
13. Kondratenko TIa, Kuzina NV, Severin ES, et al (1991). Beta- Adrenergic and muscarinic acetylcholine receptors in human lung parenchyma in malignant neoplasms. Vopr Med Khim, 37, 20-1.
14. Kondratenko TY, Zacharova IV, Kuzina NV, et al (1993). Alterations in human lung adrenergic receptors in cancer. Biochem Mol Biol Int, 29, 123-30.
15. Laag E, Majidi M, Cekanova M, et al (2006). NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int J Cancer, 119, 1547-52.
16. Masur K, Niggemann B, Zanker KS, et al (2001). Norepinephrineinduced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res, 61, 2866-9.
17. Morin D, Zini R, Lange F, et al (1987). Alterations of betaadrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lungtumors. Int J Clin Pharmacol Ther Toxicol, 25, 605-8.
18. Palm D, Lang K, Niggemann B, et al (2006). The norepinephrinedriven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by betablockers. Int J Cancer, 118, 2744-9.
19. Powe DG, Voss MJ, Zänker KS, et al (2010). Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improvescancer specific survival. Oncotarget, 1, 628-38.
20. Salpeter SS, Ormiston T, Salpeter E, et al (2002). Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2, 3566.
21. Schuller HM, OrloffM (1998). Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol, 55, 1377-83.
22. Schuller HM, Tithof PK, Williams M, et al (1999). The tobaccospecific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res, 59, 4510-5.
23. Schuller HM, Porter B, Riechert A (2000). Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol, 126, 624-30.
24. Schuller HM, Cekanova M (2005). NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer, 49, 35-45.
25. Schuller HM (2008). Neurotransmission and cancer: Implications for prevention and therapy. Anticancer Drugs, 19, 655-71.
26. Schuller HM (2009). Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer, 9, 195-205.
27. Shah SM, Carey IM, Owen CG, et al (2011). Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol, 72, 157-61.
28. Sood AK, Bhatty R, Kamat AA, et al (2006). Stress hormonemediated invasion of ovarian cancer cells. Clin Cancer Res, 12, 369-75.
29. Thaker PH, Han LY, Kamat AA, et al (2006). Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med, 12, 939-44.
30. Wang HM, Liao ZX, Komaki R, et al (2013). Improved survival outcomes with the incidental use of beta-blockers among patients with non-small -cell lung cancer treated with definitive radiation therapy. Ann Oncol, 24, 1312-9.
31. West KA, Linnoila IR, Belinsky SA, et al (2004). Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res, 64, 446-51.
32. Wong HP, Yu L, Lam EK, et al (2007). Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci, 97, 279-87.
33. Wong HP, Yu L, Lam EK, et al (2007). Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol, 221, 261-7.
34. Wong DL, Tai TC, Wong-Faull DC, et al (2011). Epinephrine: A short- and long-term regulator of stress and development of illness: A potential new role for epinephrine in stress. Cell Mol Neurobiol, 32, 737-48.